|
[1]
|
Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, et al. Disease manifestations and pathogenic mechanisms of group A Streptococcus. Clin Microbiol Rev 2014;27(2):264 − 301. http://dx.doi.org/10.1128/CMR.00101-13CrossRef
|
|
[2]
|
You Y, Davies MR, Protani M, McIntyre L, Walker MJ, Zhang J. Scarlet fever epidemic in China caused by Streptococcus pyogenes serotype M12: epidemiologic and molecular analysis. E Bio Medicine 2018;28:128 − 35. http://dx.doi.org/10.1016/j.ebiom.2018.01.010CrossRef
|
|
[3]
|
Kim JH, Cheong HK. Increasing number of scarlet fever cases, South Korea, 2011-2016. Emerging Infectious Diseases 2018;24(1):172 − 3. http://dx.doi.org/10.3201/eid2401.171027CrossRef
|
|
[4]
|
Yung CF, Thoon KC. A 12 year outbreak of scarlet fever in Singapore. Lancet Infect Dis 2018;18(9): 942. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(18)30464-X/fulltext.https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(18)30464-X/fulltext |
|
[5]
|
Lamagni T, Guy R, Chand M, Henderson KL, Chalker V, Lewis J, et al. Resurgence of scarlet fever in England, 2014-16: a population-based surveillance study. Lancet Infect Dis 2018;18(2):180 − 7. http://dx.doi.org/10.1016/S1473-3099(17)30693-XCrossRef
|
|
[6]
|
Brockmann SO, Eichner L, Eichner M. Constantly high incidence of scarlet fever in Germany. Lancet Infect Dis 2018;18(2018):499 − 500. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(18)30210-X/fulltext.https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(18)30210-X/fulltext |
|
[7]
|
Walker MJ, Brouwer S, Forde BM, Worthing KA, McIntyre L, Sundac L, et al. Detection of epidemic scarlet fever group A Streptococcus in Australia. Clin Infect Dis 2019;69(7):1232 − 4. http://dx.doi.org/10.1093/cid/ciz099CrossRef
|
|
[8]
|
You Y, Davies MR, Walker MJ, Zhang J. Hypotheses for the resurgence of scarlet fever in China. Lancet Infect Dis 2018;18(9): 942 − 3. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(18)30470-5/fulltext.https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(18)30470-5/fulltext |
|
[9]
|
Davies MR, Holden MT, Coupland P, Chen JH, Venturini C, Barnett TC, et al. Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance. Nat. Genet 2015;47(1):84 − 7. http://dx.doi.org/10.1038/ng.3147CrossRef
|
|
[10]
|
Lynskey NN, Jauneikaite E, Li HK, Zhi X, Turner CE, Mosavie M, et al. Emergence of dominant toxigenic M1T1 Streptococcus 1 pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study. Lancet Infect Dis 2019;19(11):1209 − 18. http://dx.doi.org/10.1016/S1473-3099(19)30446-3CrossRef
|